Enveric Biosciences, Inc. (ENVB)

1.43 +0.02 (+1.42%) USD  |  NASDAQ  |  Aug 25, 10:39
More

Enveric Biosciences Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for ENVB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2023. Start Trial.
Date Value
April 02, 2024 --
December 29, 2023 --
November 20, 2023 --
Date Value
October 03, 2023 --
August 24, 2023 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
LENZ Therapeutics, Inc. Upgrade
Impact BioMedical, Inc. --
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade